-
US Regulators Clear Remdesivir for COVID-19 Outpatient Use -
FDA Approves First Treatment for COVID-19, Remdesivir -
EU Buys Remdesivir to Treat 30,000 COVID Patients, Seeks More -
Gilead’s $2,340 Price for Coronavirus Drug Draws Criticism -
NIH Trial: Gilead’s Drug Works Best in COVID Patients on Oxygen -
Remdesivir Explained—What Makes This Drug Work Against Viruses? -
3,000 Participants Added to Trials for Experimental COVID-19 Treatment -
CCP Virus Patients Rush to Join Studies of Gilead Drug -
How Much of Our Tax Money Goes to Big Pharma? A Lot. -
Drug Maker Was Focused on Profits, Not Patients: Report